Mediclinic International reports robust half year

Thu, 14th Nov 2019

In its results for the six months ended 30 September 2019, Mediclinic International announced a 9% growth in revenue. The company also declared an interim dividend maintained at 3.20p per share. Adjusted EBITDA was up 4% at £222m, while adjusted earnings per share were flat at 10.3p. According to the half year report, adjusted operating profit remained flat at £137m, reflecting increased depreciation charges associated with infrastructure and technology investments. Reported operating profit rose 264% to £142m, reflecting prior year period non-cash Hirslanden impairment charges of £98m Story provided by

FTSE 100 Latest